Biocartis Group NV announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was EUR 55.559 million compared to EUR 37.732 million a year ago. Operating loss was EUR 46.862 million compared to EUR 55.602 million a year ago. Net loss was EUR 62.934 million compared to EUR 64.068 million a year ago. Basic loss per share from continuing operations was EUR 1.11 compared to EUR 1.14 a year ago.